Vertex PharmaceuticalsVRTX 
$447.50-4.63%24h
-4.63%24h
Global rank121
Market cap$115.32B
Change 7d-4.08%
YTD Performance10.49%
SP500 benchmarkUnderperform
P/E32.22
P/S11.68
Revenue$9.87B
Earnings$3.62B
Dividend yield-
Main Sector
Healthcare
Vertex Pharmaceuticals Revenue data
According to Vertex Pharmaceuticals latest financial reports the company had revenue of $9.87B in 2023-12-31, a 10.51% increase from 2022. Vertex Pharmaceuticals highest revenue was $9.87B in 2023.
Revenue history for Vertex Pharmaceuticals from 2020 to 2024
-
Value:-
Vertex Pharmaceuticals revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $9.87B | 10.51% |
| 2022 | $8.93B | 17.91% |
| 2021 | $7.57B | 22.06% |
| 2020 | $6.21B | - |
View the top revenue stocks 
